| Cullen Brody Richardson, DPT | |
|
5036 Goodman Rd, Olive Branch, MS 38654-7966 | |
| (662) 856-2989 | |
| Not Available |
| Full Name | Cullen Brody Richardson |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 5036 Goodman Rd, Olive Branch, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255963534 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT6840 (Mississippi) | Primary |
| Provider Name | Drayer Physical Therapy Mississippi Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1952732448 PECOS PAC ID: 3274834858 Enrollment ID: O20160314001040 |
News Archive
TessArae, LLC, a privately held company, and Affymetrix Inc., (NASDAQ:AFFX) today announced that the Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to TessArae for its TessArray® Resequencing Influenza A Microarray Detection Panel for the Detection of the 2009 H1N1 Influenza A Virus (TessArray RM-Flu test) for the duration of the declaration of emergency unless revoked earlier. The declaration of emergency will expire on April 26, 2010, unless terminated earlier or renewed.
Although some previous studies have suggested an increased risk of bladder cancer with use of the diabetes drug pioglitazone, analyses that included nearly 200,000 patients found no statistically significant increased risk, however a small increased risk could not be excluded, according to a study in the July 21 issue of JAMA.
China Pharmaceuticals, Inc., one of China's leading manufacturers and distributors of prescription and over-the-counter pharmaceuticals, today announced record financial results for its second quarter ended June 30, 2010.
In a world-first breakthrough, University of New South Wales (UNSW) medical researchers have used stem cells cultured on a simple contact lens to restore sight to sufferers of blinding corneal disease.
› Verified 2 days ago
| Provider Name | Endurance Physical Therapy |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1124538863 PECOS PAC ID: 8325306228 Enrollment ID: O20180205002547 |
News Archive
TessArae, LLC, a privately held company, and Affymetrix Inc., (NASDAQ:AFFX) today announced that the Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to TessArae for its TessArray® Resequencing Influenza A Microarray Detection Panel for the Detection of the 2009 H1N1 Influenza A Virus (TessArray RM-Flu test) for the duration of the declaration of emergency unless revoked earlier. The declaration of emergency will expire on April 26, 2010, unless terminated earlier or renewed.
Although some previous studies have suggested an increased risk of bladder cancer with use of the diabetes drug pioglitazone, analyses that included nearly 200,000 patients found no statistically significant increased risk, however a small increased risk could not be excluded, according to a study in the July 21 issue of JAMA.
China Pharmaceuticals, Inc., one of China's leading manufacturers and distributors of prescription and over-the-counter pharmaceuticals, today announced record financial results for its second quarter ended June 30, 2010.
In a world-first breakthrough, University of New South Wales (UNSW) medical researchers have used stem cells cultured on a simple contact lens to restore sight to sufferers of blinding corneal disease.
› Verified 2 days ago
| Provider Name | Athletico Ltd |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1477224814 PECOS PAC ID: 4789602681 Enrollment ID: O20211115001046 |
News Archive
TessArae, LLC, a privately held company, and Affymetrix Inc., (NASDAQ:AFFX) today announced that the Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to TessArae for its TessArray® Resequencing Influenza A Microarray Detection Panel for the Detection of the 2009 H1N1 Influenza A Virus (TessArray RM-Flu test) for the duration of the declaration of emergency unless revoked earlier. The declaration of emergency will expire on April 26, 2010, unless terminated earlier or renewed.
Although some previous studies have suggested an increased risk of bladder cancer with use of the diabetes drug pioglitazone, analyses that included nearly 200,000 patients found no statistically significant increased risk, however a small increased risk could not be excluded, according to a study in the July 21 issue of JAMA.
China Pharmaceuticals, Inc., one of China's leading manufacturers and distributors of prescription and over-the-counter pharmaceuticals, today announced record financial results for its second quarter ended June 30, 2010.
In a world-first breakthrough, University of New South Wales (UNSW) medical researchers have used stem cells cultured on a simple contact lens to restore sight to sufferers of blinding corneal disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cullen Brody Richardson, DPT 171 Lakewood Dr Ste 2, Batesville, MS 38606-3017 Ph: (662) 563-2579 | Cullen Brody Richardson, DPT 5036 Goodman Rd, Olive Branch, MS 38654-7966 Ph: (662) 856-2989 |
News Archive
TessArae, LLC, a privately held company, and Affymetrix Inc., (NASDAQ:AFFX) today announced that the Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to TessArae for its TessArray® Resequencing Influenza A Microarray Detection Panel for the Detection of the 2009 H1N1 Influenza A Virus (TessArray RM-Flu test) for the duration of the declaration of emergency unless revoked earlier. The declaration of emergency will expire on April 26, 2010, unless terminated earlier or renewed.
Although some previous studies have suggested an increased risk of bladder cancer with use of the diabetes drug pioglitazone, analyses that included nearly 200,000 patients found no statistically significant increased risk, however a small increased risk could not be excluded, according to a study in the July 21 issue of JAMA.
China Pharmaceuticals, Inc., one of China's leading manufacturers and distributors of prescription and over-the-counter pharmaceuticals, today announced record financial results for its second quarter ended June 30, 2010.
In a world-first breakthrough, University of New South Wales (UNSW) medical researchers have used stem cells cultured on a simple contact lens to restore sight to sufferers of blinding corneal disease.
› Verified 2 days ago
Nicholas Bailey, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8110 Camp Creek Rd Ste 106, Olive Branch, MS 38654 Phone: 662-893-1933 Fax: 662-893-1934 | |
Tina Marie Erber, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4780 Medora Dr, Olive Branch, MS 38654 Phone: 662-895-1891 | |
Exos Physical Therapy & Sports Medicine, Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 6542 Goodman Rd Ste 101, Olive Branch, MS 38654 Phone: 205-259-3991 | |
Joshua Mark Day, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8110 Camp Creek Rd Ste 106, Olive Branch, MS 38654 Phone: 662-893-1933 Fax: 662-893-1934 | |
Tarah L Rudd, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4578 Pleasant Breeze Dr, Olive Branch, MS 38654 Phone: 901-268-9759 | |
Holly Johnson, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2268 Ross Rd, Olive Branch, MS 38654 Phone: 662-808-2680 Fax: 662-895-0566 | |
Blake Jordan Falconello, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 6542 Goodman Rd Ste 101, Olive Branch, MS 38654 Phone: 662-874-5964 Fax: 662-874-5176 |